Char DH. Ocular melanoma. Surg Clin North Am. 2003;83(2):253–74.

Article  PubMed  Google Scholar 

Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24.

Article  PubMed  Google Scholar 

Chang AE, Karnell LH, Menck HR. The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American college of surgeons commission on cancer and the American cancer society. Cancer. 1998;83(8):1664–78.

Article  CAS  PubMed  Google Scholar 

Singh AD, Belfort RN, Sayanagi K, Kaiser PK. Fourier domain optical coherence tomographic and auto-fluorescence findings in indeterminate choroidal melanocytic lesions. Br J Ophthalmol. 2010;94(4):474–8.

Article  PubMed  Google Scholar 

Koc I, Kiratli H. Current management of conjunctival melanoma part 1: clinical features, diagnosis and histopathology. Turk J Ophthalmol. 2020;50(5):293–303.

Article  PubMed  PubMed Central  Google Scholar 

Shields JA, Shields CL. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture. Ophthalmology. 2015;122(2):414–28.

Article  PubMed  Google Scholar 

Koc I, Kiratli H. Current management of conjunctival melanoma part 2: treatment and future directions. Turk J Ophthalmol. 2020;50(6):362–70.

Article  PubMed  PubMed Central  Google Scholar 

Collaborative Ocular Melanoma Study G. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol. 2001;119(5):670–6.

Article  Google Scholar 

Shields CL. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc. 2000;98:471–92.

CAS  PubMed  PubMed Central  Google Scholar 

Damato BE, Heimann H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 2014;132(5):605–13.

Article  PubMed  Google Scholar 

Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127(8):989–98.

Article  PubMed  Google Scholar 

Tuomaala S, Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for Sentinel lymph node biopsy. Ophthalmology. 2004;111(4):816–21.

Article  PubMed  Google Scholar 

Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, et al. Advances in the clinical management of uveal melanoma. Nat Rev Clin Oncol. 2023;20(2):99–115.

Article  PubMed  Google Scholar 

Nahon-Esteve S, Bertolotto C, Picard-Gauci A, Gastaud L, Baillif S, Hofman P, et al. Small but challenging conjunctival melanoma: new insights, paradigms and future perspectives. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13225691.

Article  PubMed  Google Scholar 

Zeiger JS, Lally SE, Dalvin LA, Shields CL. Advances in conjunctival melanoma: clinical features, diagnostic modalities, staging, genetic markers, and management. Can J Ophthalmol. 2024;59(4):209–17.

Article  PubMed  Google Scholar 

Gunduz AK, Mirzayev I. Surgical approach in intraocular tumors. Turk J Ophthalmol. 2022;52(2):125–38.

Article  PubMed  PubMed Central  Google Scholar 

Vora GK, Demirci H, Marr B, Mruthyunjaya P. Advances in the management of conjunctival melanoma. Surv Ophthalmol. 2017;62(1):26–42.

Article  PubMed  Google Scholar 

Shields CL, Chien JL, Surakiatchanukul T, Sioufi K, Lally SE, Shields JA. Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes–the 2017 J. Donald M. Gass lecture. Asia Pac J Ophthalmol (Phila). 2017;6(2):109–20.

PubMed  Google Scholar 

Shields JA, Shields CL, Mashayekhi A, Marr BP, Benavides R, Thangappan A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Trans Am Ophthalmol Soc. 2007;105:61–71. discussion – 2.

PubMed  PubMed Central  Google Scholar 

Alzahrani YA, Kumar S, Abdul Aziz H, Plesec T, Singh AD. Primary acquired melanosis: clinical, histopathologic and optical coherence tomographic correlation. Ocul Oncol Pathol. 2016;2(3):123–7.

Article  PubMed  Google Scholar 

Cohen VML, O’Day RF. Management issues in conjunctival tumours: conjunctival melanoma and primary acquired melanosis. Ophthalmol Ther. 2019;8(4):501–10.

Article  PubMed  PubMed Central  Google Scholar 

Mor JM, Rokohl AC, Koch KR, Heindl LM. Sentinel lymph node biopsy in the management of conjunctival melanoma: current insights. Clin Ophthalmol. 2019;13:1297–302.

Article  PubMed  PubMed Central  Google Scholar 

Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, et al. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol. 2017;95(4):e323–8.

Article  CAS  PubMed  Google Scholar 

Shields JA, Shields CL, Gunduz K, Cater J. Clinical features predictive of orbital exenteration for conjunctival melanoma. Ophthalmic Plast Reconstr Surg. 2000;16(3):173–8.

Article  CAS  PubMed  Google Scholar 

Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol. 1998;82(5):476–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finger PT, Milner MS, McCormick SA. Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol. 1993;77(11):751–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demirci H, McCormick SA, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol. 2000;118(7):885–91.

CAS  PubMed  Google Scholar 

Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108–14.

Article  CAS  PubMed  Google Scholar 

Finger PT, Sedeek RW, Chin KJ. Topical interferon Alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol. 2008;145(1):124–9.

Article  CAS  PubMed  Google Scholar 

Westekemper H, Freistuehler M, Anastassiou G, Nareyeck G, Bornfeld N, Steuhl KP, et al. Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinations. Br J Ophthalmol. 2012;96(4):591–6.

Article  PubMed  Google Scholar 

Westekemper H, Freistuehler M, Bornfeld N, Steuhl KP, Scheulen M, Hilger RA. Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents. Graefes Arch Clin Exp Ophthalmol. 2013;251(1):279–84.

Article  CAS  PubMed  Google Scholar 

Cunneen TS, Conway RM, Madigan MC. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. Arch Ophthalmol. 2009;127(4):414–20.

Article  CAS  PubMed  Google Scholar 

Spatola C, Liardo RL, Milazzotto R, Raffaele L, Salamone V, Basile A, et al. Radiotherapy of conjunctival melanoma: role and challenges. Appl Sci. 2020;10(24):9071.

Article  CAS